The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Research in Temporal Arteritis Suggests Link with Infection, Autoimmune Disease

Research in Temporal Arteritis Suggests Link with Infection, Autoimmune Disease

November 16, 2015 • By Shamik Bhattacharyya, MD, MS

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Temporal arteritis was first described by Sir Jonathan Hutchinson in 1890 in an elderly retired gentleman’s servant who developed red, painful streaks on his temples and was found to have bilaterally swollen temporal arteries with feeble pulses.1 Sir Hutchinson disputed the suggestion that the red streaks were caused by the man’s hat and, instead, called his observation, albeit without histology, “an unquestionable example of an arteritis, which spread along the affected vessels, causing swelling of the external coats and adjacent cellular tissue which resulted very quickly in occlusion of the vessels.”

You Might Also Like
  • Varicella Zoster Virus May Cause Giant Cell Arteritis
  • Giant Cell Arteritis
  • How to Manage Patients with Giant Cell Arteritis and Polymyalgia Rheumatica
Explore This Issue
November 2015
Temporal arteritis is a form of the medium- to large-vessel arteritis named giant cell arteritis.

Temporal arteritis is a form of the medium to large vessel arteritis named giant cell arteritis.

Pathology

More than a century has passed since this initial observation, but the sequence of events precipitating the arteritis remains unclear.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Temporal arteritis is now recognized to be a form of the medium- to large-vessel arteritis named giant cell arteritis (GCA) because of characteristic giant cells seen on histology. In addition to branches of the external carotid artery, GCA can affect many other vascular territories, including the ophthalmic artery, causing vision loss in 10–15% of patients; the vertebrobasilar arteries, causing ischemic stroke; the aorta, causing dissection or aneurysm formation; and the subclavian arteries, causing claudication.2,3 The temporal artery biopsy typically demonstrates mononuclear inflammatory infiltrates in the vessel wall, with fragmentation of the elastic lamina. The lumen is often occluded from intimal hyperplasia. Giant cells, when found, are found at the intima-media border.4

There may be an association between VZV & GCA rather than causation.

GCA Trigger

The pathologic features, however, don’t provide an etiology. In the May 12, 2015, issue of Neurology, Don Gilden, MD, professor of neurology at the University of Colorado in Aurora, and colleagues published provocative evidence that varicella zoster virus (VZV) may trigger GCA.5 They examined 82 formalin-fixed biopsy specimens of histologically confirmed GCA along with 13 cadaveric temporal artery controls. Strikingly, immunohistochemical analysis of the arterial wall for VZV gE antigen (produced in infected cells) was positive in 74% of the GCA cases compared with only one positive finding in the control arteries. As is characteristic of GCA pathology, there were “skip areas” where VZV was absent. GCA pathology in 89% of cases tended to be adjacent to regions containing the VZV antigen. In almost half of the cases, the VZV antigen was found in the adventitia of the arterial wall.

The authors confirmed the immunohistochemical findings using other techniques, as well. VZV DNA was detected using polymerase chain reaction (PCR) in 40% of the lesions that were positive using immunohistochemistry. Electron microscopy on a single specimen showed enveloped viral particles within the vessel wall.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 | Single Page

Filed Under: Conditions, Systemic Inflammatory Syndromes, Vasculitis Tagged With: Autoimmune disease, Cause, Giant Cell Arteritis, Infection, Research, rheumatology, temporal arteritis, varicella zoster virusIssue: November 2015

You Might Also Like:
  • Varicella Zoster Virus May Cause Giant Cell Arteritis
  • Giant Cell Arteritis
  • How to Manage Patients with Giant Cell Arteritis and Polymyalgia Rheumatica
  • Abatacept Plus Prednisone Therapy Studied for Treating Giant Cell Arteritis

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)